Exodus Point Capital Management, LP Haemonetics Corp Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 14,443 shares of HAE stock, worth $927,962. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,443
Previous 80,943
82.16%
Holding current value
$927,962
Previous $6.51 Million
82.66%
% of portfolio
0.01%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding HAE
# of Institutions
347Shares Held
51.8MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$383 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$333 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$284 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$272 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$164 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.3B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...